Arizona State Retirement System lowered its stake in CME Group Inc. (NASDAQ:CME) by 2.6% during the second quarter, Holdings Channel reports. The fund owned 123,503 shares of the financial services provider’s stock after selling 3,300 shares during the period. Arizona State Retirement System’s holdings in CME Group were worth $15,468,000 as of its most recent filing with the SEC.
Several other institutional investors have also recently modified their holdings of the company. BlackRock Inc. raised its position in shares of CME Group by 2,172.6% in the first quarter. BlackRock Inc. now owns 27,265,611 shares of the financial services provider’s stock valued at $3,239,152,000 after buying an additional 26,065,883 shares during the last quarter. Edgewood Management LLC raised its position in shares of CME Group by 26.4% in the first quarter. Edgewood Management LLC now owns 7,228,349 shares of the financial services provider’s stock valued at $858,728,000 after buying an additional 1,511,753 shares during the last quarter. APG Asset Management N.V. raised its position in shares of CME Group by 335.2% in the first quarter. APG Asset Management N.V. now owns 1,899,723 shares of the financial services provider’s stock valued at $225,687,000 after buying an additional 1,463,198 shares during the last quarter. Vanguard Group Inc. raised its position in shares of CME Group by 3.8% in the first quarter. Vanguard Group Inc. now owns 22,232,434 shares of the financial services provider’s stock valued at $2,641,214,000 after buying an additional 806,282 shares during the last quarter. Finally, Wells Fargo & Company MN raised its position in shares of CME Group by 25.5% in the first quarter. Wells Fargo & Company MN now owns 3,490,351 shares of the financial services provider’s stock valued at $414,653,000 after buying an additional 709,012 shares during the last quarter. 83.29% of the stock is currently owned by institutional investors.
CME Group Inc. (NASDAQ CME) opened at 124.19 on Friday. The company’s 50 day moving average price is $123.43 and its 200-day moving average price is $120.91. The stock has a market cap of $42.21 billion, a price-to-earnings ratio of 25.35 and a beta of 0.73. CME Group Inc. has a 12-month low of $98.95 and a 12-month high of $127.96.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business had revenue of $925 million during the quarter, compared to the consensus estimate of $931.05 million. During the same quarter in the prior year, the firm earned $1.14 EPS. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. On average, analysts forecast that CME Group Inc. will post $4.81 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date of this dividend is Thursday, September 7th. CME Group’s dividend payout ratio is presently 53.99%.
Several equities analysts have issued reports on CME shares. Royal Bank Of Canada dropped their price objective on CME Group from $134.00 to $133.00 and set an “outperform” rating on the stock in a report on Wednesday, April 19th. Deutsche Bank AG reaffirmed a “buy” rating and set a $133.00 price objective (down previously from $134.00) on shares of CME Group in a report on Monday, May 15th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. BidaskClub raised CME Group from a “sell” rating to a “hold” rating in a report on Friday, June 23rd. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $134.00 price objective (up previously from $128.00) on shares of CME Group in a report on Monday, July 17th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $131.63.
In other CME Group news, Director Ronald A. Pankau sold 300 shares of the company’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $124.78, for a total value of $37,434.00. Following the completion of the transaction, the director now owns 4,009 shares in the company, valued at approximately $500,243.02. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Chairman Terrence A. Duffy sold 21,815 shares of the company’s stock in a transaction dated Wednesday, August 2nd. The stock was sold at an average price of $123.89, for a total transaction of $2,702,660.35. Following the completion of the transaction, the chairman now owns 110,711 shares of the company’s stock, valued at approximately $13,715,985.79. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 90,885 shares of company stock valued at $11,217,668. Insiders own 0.61% of the company’s stock.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.